Two Sigma Investments’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
Two Sigma Investments's STOK Position: Q3 2026 in Review
Two Sigma Investments increased its Stoke Therapeutics (STOK) stake by 234% in Q3 2026, buying an estimated $4.41M and bringing the position to 208,471 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.
Two Sigma Investments first reported a position in STOK in Q4 2020 and has held it in 19 quarters since. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- Two Sigma Investments held 208,471 shares of Stoke Therapeutics worth $5.42M as of Q3 2026.
- Two Sigma Investments bought 146,100 Stoke Therapeutics shares in Q3 2026, an estimated $4.41M.
- Stoke Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #2091 holding.
- Two Sigma Investments first reported a position in Stoke Therapeutics in Q4 2020 and has held it in 19 quarters since.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.